Sector revisions Monte Rosa Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 04:00:00 2026-08-20 pm EDT			5-day change	1st Jan Change
14.78 ^USD	-6.28%		-6.69%	-5.74%

Aug. 06	Monte Rosa Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
Aug. 06	Earnings Flash (GLUE) Monte Rosa Therapeutics, Inc. Reports Q2 Collaboration Revenue $9.0M, vs. FactSet Est of $12.9M	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
MONTE ROSA THERAPEUTICS, INC.		6
LONZA GROUP AG		23
REVOLUTION MEDICINES, INC.		21
BEONE MEDICINES AG		27
IQVIA HOLDINGS INC.		18
CELLTRION, INC.		23
ASCENDIS PHARMA A/S	-	19
MEDPACE HOLDINGS, INC.		12
EUROFINS SCIENTIFIC SE		14
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		14
ICON PUBLIC LIMITED COMPANY		16
PHARMARON BEIJING CO., LTD.		11
BIO-TECHNE CORPORATION		11
TEMPUS AI, INC.		14
PRAXIS PRECISION MEDICINES, INC.		19
KYMERA THERAPEUTICS, INC.		22
ABIVAX		6
APOGEE THERAPEUTICS, INC.		11
IONIS PHARMACEUTICALS, INC.		22
PROTAGONIST THERAPEUTICS, INC.		13
Average		16
Weighted average by Cap.		19